carbostyril has been researched along with Precancerous Conditions in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Hartgerink, JD; Leach, DG; Myers, JN; Osman, AA; Rangel, R; Ren, X; Shi, Y; Sikora, AG; Wang, B; Xie, TX; Young, S | 1 |
Caulin, C; El-Naggar, AK; Heymach, JV; Myers, JN; Wang, B; Wang, J; William, WN; Xie, T | 1 |
Chen, X; Cheng, B; Hu, Q; Wang, C; Wu, T; Xia, J; Yang, L | 1 |
El-Naggar, AK; Fan, YH; Feng, L; Foy, JP; Hong, WK; Kim, ES; Lang, W; Lee, JJ; Lingen, MW; Lippman, SM; Mao, L; Papadimitrakopoulou, V; Saintigny, P; William, WN; Zhang, L | 1 |
Barcessat, AR; CorrĂȘa, L; de Cerqueira Luz, JG; Ferreira, LG; Huang, I; Rabelo, GD; Rosin, FC | 1 |
Alvarenga, TA; Andersen, ML; Marchi, P; Noguti, J; Oshima, CT; Ribeiro, DA | 1 |
Chen, X; Han, X; Jiang, K; Li, S; Wang, B; Zhou, L | 1 |
Aza-Blanc, P; Barile, E; Bosenberg, M; Chin, L; De, SK; Feng, Y; Jackson, M; Krajewski, S; Lau, E; Pellecchia, M; Pinkerton, AB; Ronai, ZA; Ruller, C; Scortegagna, M; Williams, R | 1 |
Khuri, FR | 1 |
Denda, A; Inoue, M; Kirita, T; Kitayama, W; Kuniyasu, H; Morisaki, A; Yamamoto, K | 1 |
Honjo, S; Kawabata, K; Kohno, H; Murakami, M; Ota, T; Tanaka, T; Tsuda, H | 1 |
1 review(s) available for carbostyril and Precancerous Conditions
Article | Year |
---|---|
Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemoprevention; Clinical Trials as Topic; Disease Progression; Epidermal Growth Factor; Gefitinib; Humans; Lung Neoplasms; Precancerous Conditions; Protein-Tyrosine Kinases; Quinazolines; Quinolones | 2003 |
2 trial(s) available for carbostyril and Precancerous Conditions
Article | Year |
---|---|
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Crizotinib; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genomics; Head and Neck Neoplasms; Humans; Leukoplakia, Oral; Male; Mice, Inbred CBA; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Precancerous Conditions; Prognosis; Prospective Studies; Proto-Oncogene Proteins c-met; Pyrrolidinones; Quinolines; Quinolones; Survival Rate; Tumor Cells, Cultured | 2018 |
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
Topics: Alanine; CDX2 Transcription Factor; Disease Progression; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Homeodomain Proteins; Humans; Male; Metaplasia; Middle Aged; Peptides; Precancerous Conditions; Quinolones; Stomach Neoplasms; Trefoil Factor-3 | 2015 |
8 other study(ies) available for carbostyril and Precancerous Conditions
Article | Year |
---|---|
Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antibodies, Monoclonal; Carcinogenesis; Disease Models, Animal; Drug Delivery Systems; Female; Genes, p53; Head and Neck Neoplasms; Humans; Immune Checkpoint Inhibitors; Injections, Intralesional; Male; Mice; Mice, Transgenic; Mouth Neoplasms; Precancerous Conditions; Programmed Cell Death 1 Receptor; Quinolones; Squamous Cell Carcinoma of Head and Neck | 2021 |
PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antibodies, Monoclonal; Apoptosis; Carcinogens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Progression; Female; Granzymes; Immunoglobulin G; Immunohistochemistry; Interferon-gamma; Ligands; Mice; Mice, Inbred C57BL; Mouth Neoplasms; Precancerous Conditions; Programmed Cell Death 1 Receptor; Quinolones; STAT1 Transcription Factor | 2017 |
Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation.
Topics: 4-Nitroquinoline-1-oxide; Adult; Aged; Animals; Apoptosis; Biomarkers, Tumor; Carcinogenesis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Disulfides; Female; Humans; Imidazoles; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Orthognathic Surgical Procedures; Oxidative Stress; Precancerous Conditions; Proteomics; Quinolones; Rats, Sprague-Dawley; Reactive Oxygen Species; Thioredoxins; Tongue | 2018 |
Systemic toxic effects during early phases of topical 4-NQO-induced oral carcinogenesis in rats.
Topics: 4-Nitroquinoline-1-oxide; Administration, Topical; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Chemical Analysis; Carcinogenesis; Carcinogens; Female; Keratinocytes; Kidney Tubules; Leukocyte Count; Leukoplakia, Oral; Liver; Monocytes; Pancreas; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Quinolones; Rats; Rats, Wistar; Serum Albumin; Spleen; Submandibular Gland; Tongue; Tongue Neoplasms; Weight Gain | 2014 |
The influence of sleep restriction on expression of apoptosis regulatory proteins p53, Bcl-2 and Bax following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Carcinogenesis; Carcinogens; Cell Proliferation; Epithelium; Leukoplakia, Oral; Male; Precancerous Conditions; Proto-Oncogene Proteins c-bcl-2; Quinolones; Random Allocation; Rats; Rats, Wistar; Sleep; Sleep Wake Disorders; Time Factors; Tongue Neoplasms; Tumor Suppressor Protein p53 | 2015 |
Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.
Topics: Amino Acid Substitution; Animals; Benzimidazoles; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Injections, Intraperitoneal; Ki-67 Antigen; Leukocyte Common Antigens; Melanoma; Mice; Precancerous Conditions; Proto-Oncogene Proteins B-raf; Quinolones; ras Proteins; Skin Neoplasms; Small Molecule Libraries; Xenograft Model Antitumor Assays | 2013 |
Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Etodolac; Immunohistochemistry; Male; Precancerous Conditions; Quinolones; Rats; Rats, Inbred F344; Tongue; Tongue Neoplasms; Water Supply | 2004 |
Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.
Topics: 4-Nitroquinoline-1-oxide; Animals; Body Weight; Carcinogens; Cattle; Epithelium; Glutathione Transferase; Immunohistochemistry; Lactoferrin; Liver; Male; Mucous Membrane; NAD(P)H Dehydrogenase (Quinone); Organ Size; Ornithine Decarboxylase; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Quinolones; Rats; Rats, Inbred F344; Tongue; Tongue Neoplasms | 2000 |